Connect with us


Higher Ground Holdings to Apparently Acquire High Times and Multiple Cannabis Content Platforms



Higher Ground Holdings to Acquire High Times and Multiple Cannabis Content Platforms
- Ad -

In what appears to be a ‘messy news release', Higher Ground Holding LLCBD, announced the purchase of various cannabis websites and magazines in an effort to centralize the content, according to a report by MJ News Network.

Michael A. Stusser, the CEO of the publication, spoke at MJ BizCon in Las Vegas. There, he stated that the deal has been in the works for a long time, “How many stories about Seth Rogen or close-up pics of stank bud do you really need?” and that the acquisition will enable the publication to consolidate a number of marijuana brands and “by that I mean snuff ém out like a smokin’ roach.” The article, which seems to want to be taken seriously, it stuffed with a bit of jargon that is hard to understand and possibly/apparently even factually wrong.

According to the report, several of the publications acquired by Higher Ground Holding, LLCBD, include: Marijuana Business Daily, Sensi, Skunk, Grow, Marijuana Venture, Merry Jane, mg Retailer, Civilized, the Fresh Toast, Herb, CULTURE, Green Entrepreneur, Ganjapreneur, Freedom Leaf, Gossamer, Broccoli, Cannabis Now and MassRoots, not to mention, “We also tried to buy Future State Brands (PROHBTD), MedMen (Embers) and Civilized (New Frontier Data),” noted Higher Ground’s CFO “but by the time we got the paperwork lined up, they’d all burned through so much seed money, they had to abandon their swank offices – and we had no way to reach them.”

Since the purchase, the publication has implemented a new rule called the “Tommy Chong Rule, which means that Cheech and Chong are apparently prohibited from being featured in any marijuana related media until the year 4020, and that there will be other future bans, including Miley Cyrus, Chelsea Handler, Willie Nelson, Snoop Dogg, Martha Stewart, and others, according to the report.

Stusser also reportedly stated that the transaction cost $9,500. Al Olsen, the Editor-in-Chief of Higher Ground, also stated in the report that the goal is to offer customized mainstream video content productions and extensions that are licensed for cannabis service agencies across the sub and pop-culture spectrum.

Reading the whole news release in full appears this clickbait content or a far stretched mixed in with some facts that are true, like High Times buying Green Rush Daily for $7 million, or Culture magazine for $4 million and Dope Magazine for $11.2 million – other than that, as the saying always goes, don't believe everything you read on the internet as truth.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or medical advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.